ATG5 and hepatocellular carcinoma: Blocking autophagy with bafilomycin A1 or knocking-down ATG5 overcomes sorafenib resistance in CD24 high expressing HCC, suggesting that CD24 could be used as a biomarker for therapeutic benefit for autophagy-inhibition in sorafenib-resistant HCC [165].